ReviewJournal of ovarian research2025
IVF and pregnancy outcomes: the triumphs, challenges, and unanswered questions.
Review in Journal of ovarian research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- How declines in fertility rates are informing responses within health systems: a protocol for a scoping review.BMJ open · 2026Article
- Epigenetic, environmental, and sex-specific programming of long-term health in Assisted Reproductive Technologies-conceived offspring†.Biology of reproduction · 2026Review
- The quintessential high-risk profile: advanced management strategies for placenta accreta spectrum in patients with advanced maternal age and IVF conception.BMC pregnancy and childbirth · 2026Review
- A retrospective study of the relationship between low-density lipoprotein cholesterol and pregnancy outcomes after assisted reproductive technology treatments in women with diabetes mellitus and infertility.AJOG global reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn vitro fertilization (IVF) has become an integral component of reproductive medicine, providing a pathway to parenthood for infertile and sub-fertile couples. Currently, IVF accounts for approximately 2-5% of all births globally. Over the past decades, the field has witnessed substantial advancements, including changes in patient demographics, embryology techniques, pharmaceutical agents, and treatment protocols.
methodsThis review examines the evolution of IVF, focusing on technological innovations and shifting patient profiles, particularly the increasing number of older women undergoing treatment.
resultsWhile technological and clinical innovations have enhanced IVF success rates and safety, they have also contributed to a broader patient population, including women with pre-existing medical conditions. These divergent trends-improved treatment efficacy alongside growing medical complexity-have reshaped the clinical and public health risk profiles associated with IVF.
conclusionsOngoing surveillance, comprehensive patient counseling, and appropriate regulatory oversight are essential to sustaining high-quality reproductive care in the context of a continually evolving IVF landscape.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.